Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer

Frozen sections of breast tumor tissue have been stained using an immunoperoxidase [estrogen receptor (ER)-immunocytochemistry] kit incorporating a monoclonal antiserum [H222] to visualize nuclear human ERs. Quantitation of specific staining has been performed by manual procedures using optical micr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 1990-06, Vol.50 (12), p.3545-3550
Hauptverfasser: MCCLELLAND, R. A, FINLAY, P, WALKER, K. J, NICHOLSON, D, ROBERTSON, J. F. R, BLAMEY, R. W, NICHOLSON, R. I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3550
container_issue 12
container_start_page 3545
container_title Cancer research (Chicago, Ill.)
container_volume 50
creator MCCLELLAND, R. A
FINLAY, P
WALKER, K. J
NICHOLSON, D
ROBERTSON, J. F. R
BLAMEY, R. W
NICHOLSON, R. I
description Frozen sections of breast tumor tissue have been stained using an immunoperoxidase [estrogen receptor (ER)-immunocytochemistry] kit incorporating a monoclonal antiserum [H222] to visualize nuclear human ERs. Quantitation of specific staining has been performed by manual procedures using optical microscopy and by a computer-assisted image analysis system (CAS 100). Initial investigations with a test panel of ER-immunocytochemistry-positive tumors revealed a good qualitative agreement between CAS and manual assessments. Reduced variance was, however, observed between quantified ER-immunocytochemistry results from four experienced investigators using the CAS analysis. An extended study confirmed the relationships between CAS and manual methods of assessment. These findings were evident when studies were scored either by assessment of the percentage of positively stained cells (n = 92; r = 0.919; P less than 0.01) or by H-score calculations (n = 92; r = 0.913; P less than 0.01). A good correlation was also found between CAS quantification and the results of an ER enzyme immunoassay of 48 primary breast cancer specimens (r = 0.715; P less than 0.05). In 49 cases it was possible to relate CAS-defined ER status and levels to the subsequent response of patients to endocrine therapy. ER was assessed on specimens obtained prior to commencement of treatments for recurrent breast cancer. Presuming the presence of ER to be a prerequisite for successful therapy, very good correlations between response and both status and levels of positivity were recorded. None of 16 patients with CAS-ER-negative tumors responded to treatment, while 16 of 33 (48.4%) CAS-ER-positive patients achieved an objective response according to International Union Against Cancer criteria. A relationship between response and the degree of CAS-ER positivity was obtained when the CAS score divisions of 0, 1-100, and greater than 100 (response rates, 0, 41, and 64%, respectively) were used. These data demonstrate that automated image analysis offers a reliable, reproducible procedure for quantifying ER in immunocytochemically stained sections. It has potential advantages over manual procedures, providing less opportunity for subjective influences in scoring sections. Future advances in software design should further reduce elements of subjectivity and increase both the speed and reliability of results. We anticipate image analysis becoming a valuable tool in investigations concerning, for example, the
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79775126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79775126</sourcerecordid><originalsourceid>FETCH-LOGICAL-p236t-33090fd21d8153415dd13ea29ae5d94b7161dc9cc2efa65dfc291ecd61b19b203</originalsourceid><addsrcrecordid>eNo9kE9LxDAQxYMo67r6EYRc9FZI0qZtjsviP1jwoueSJlM30iTdJD3UT2_A4mUew_sxzHsXaEt52RZNVfFLtCWEtAWvGnaNbmL8ziunhG_QhtG24aLdon4_J29lAo3Ps3TJJJmMd9gP2Fg7O6-W5NUJrFFyHBc8-qzmJ-MQU_Bf4HAABVPyIWLj8Gm20uE-gIwJK-kUhFt0Ncgxwt2qO_T5_PRxeC2O7y9vh_2xmFhZp6IsiSCDZlS3OUJFuda0BMmEBK5F1Te0ploJpRgMsuZ6UExQULqmPRU9I-UOPf7dnYI_z_m9zpqoYBylAz_HrhFNwymrM3i_gnNvQXdTMFaGpVtLyf7D6suY0w4hxzDxH6OirEmb5y_An25C</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79775126</pqid></control><display><type>article</type><title>Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>MCCLELLAND, R. A ; FINLAY, P ; WALKER, K. J ; NICHOLSON, D ; ROBERTSON, J. F. R ; BLAMEY, R. W ; NICHOLSON, R. I</creator><creatorcontrib>MCCLELLAND, R. A ; FINLAY, P ; WALKER, K. J ; NICHOLSON, D ; ROBERTSON, J. F. R ; BLAMEY, R. W ; NICHOLSON, R. I</creatorcontrib><description>Frozen sections of breast tumor tissue have been stained using an immunoperoxidase [estrogen receptor (ER)-immunocytochemistry] kit incorporating a monoclonal antiserum [H222] to visualize nuclear human ERs. Quantitation of specific staining has been performed by manual procedures using optical microscopy and by a computer-assisted image analysis system (CAS 100). Initial investigations with a test panel of ER-immunocytochemistry-positive tumors revealed a good qualitative agreement between CAS and manual assessments. Reduced variance was, however, observed between quantified ER-immunocytochemistry results from four experienced investigators using the CAS analysis. An extended study confirmed the relationships between CAS and manual methods of assessment. These findings were evident when studies were scored either by assessment of the percentage of positively stained cells (n = 92; r = 0.919; P less than 0.01) or by H-score calculations (n = 92; r = 0.913; P less than 0.01). A good correlation was also found between CAS quantification and the results of an ER enzyme immunoassay of 48 primary breast cancer specimens (r = 0.715; P less than 0.05). In 49 cases it was possible to relate CAS-defined ER status and levels to the subsequent response of patients to endocrine therapy. ER was assessed on specimens obtained prior to commencement of treatments for recurrent breast cancer. Presuming the presence of ER to be a prerequisite for successful therapy, very good correlations between response and both status and levels of positivity were recorded. None of 16 patients with CAS-ER-negative tumors responded to treatment, while 16 of 33 (48.4%) CAS-ER-positive patients achieved an objective response according to International Union Against Cancer criteria. A relationship between response and the degree of CAS-ER positivity was obtained when the CAS score divisions of 0, 1-100, and greater than 100 (response rates, 0, 41, and 64%, respectively) were used. These data demonstrate that automated image analysis offers a reliable, reproducible procedure for quantifying ER in immunocytochemically stained sections. It has potential advantages over manual procedures, providing less opportunity for subjective influences in scoring sections. Future advances in software design should further reduce elements of subjectivity and increase both the speed and reliability of results. We anticipate image analysis becoming a valuable tool in investigations concerning, for example, the influence of heterogeneity of steroid receptor distribution on the rate of recurrence of breast cancer after mastectomy and in the clinical course of the disease.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 2187598</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Biological and medical sciences ; Breast - analysis ; Breast Neoplasms - analysis ; Breast Neoplasms - therapy ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Image Processing, Computer-Assisted ; Immunoenzyme Techniques - instrumentation ; Mammary gland diseases ; Medical sciences ; Neoplasms, Hormone-Dependent - analysis ; Neoplasms, Hormone-Dependent - therapy ; Receptors, Estrogen - analysis ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 1990-06, Vol.50 (12), p.3545-3550</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19360819$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2187598$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MCCLELLAND, R. A</creatorcontrib><creatorcontrib>FINLAY, P</creatorcontrib><creatorcontrib>WALKER, K. J</creatorcontrib><creatorcontrib>NICHOLSON, D</creatorcontrib><creatorcontrib>ROBERTSON, J. F. R</creatorcontrib><creatorcontrib>BLAMEY, R. W</creatorcontrib><creatorcontrib>NICHOLSON, R. I</creatorcontrib><title>Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Frozen sections of breast tumor tissue have been stained using an immunoperoxidase [estrogen receptor (ER)-immunocytochemistry] kit incorporating a monoclonal antiserum [H222] to visualize nuclear human ERs. Quantitation of specific staining has been performed by manual procedures using optical microscopy and by a computer-assisted image analysis system (CAS 100). Initial investigations with a test panel of ER-immunocytochemistry-positive tumors revealed a good qualitative agreement between CAS and manual assessments. Reduced variance was, however, observed between quantified ER-immunocytochemistry results from four experienced investigators using the CAS analysis. An extended study confirmed the relationships between CAS and manual methods of assessment. These findings were evident when studies were scored either by assessment of the percentage of positively stained cells (n = 92; r = 0.919; P less than 0.01) or by H-score calculations (n = 92; r = 0.913; P less than 0.01). A good correlation was also found between CAS quantification and the results of an ER enzyme immunoassay of 48 primary breast cancer specimens (r = 0.715; P less than 0.05). In 49 cases it was possible to relate CAS-defined ER status and levels to the subsequent response of patients to endocrine therapy. ER was assessed on specimens obtained prior to commencement of treatments for recurrent breast cancer. Presuming the presence of ER to be a prerequisite for successful therapy, very good correlations between response and both status and levels of positivity were recorded. None of 16 patients with CAS-ER-negative tumors responded to treatment, while 16 of 33 (48.4%) CAS-ER-positive patients achieved an objective response according to International Union Against Cancer criteria. A relationship between response and the degree of CAS-ER positivity was obtained when the CAS score divisions of 0, 1-100, and greater than 100 (response rates, 0, 41, and 64%, respectively) were used. These data demonstrate that automated image analysis offers a reliable, reproducible procedure for quantifying ER in immunocytochemically stained sections. It has potential advantages over manual procedures, providing less opportunity for subjective influences in scoring sections. Future advances in software design should further reduce elements of subjectivity and increase both the speed and reliability of results. We anticipate image analysis becoming a valuable tool in investigations concerning, for example, the influence of heterogeneity of steroid receptor distribution on the rate of recurrence of breast cancer after mastectomy and in the clinical course of the disease.</description><subject>Biological and medical sciences</subject><subject>Breast - analysis</subject><subject>Breast Neoplasms - analysis</subject><subject>Breast Neoplasms - therapy</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>Immunoenzyme Techniques - instrumentation</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Neoplasms, Hormone-Dependent - analysis</subject><subject>Neoplasms, Hormone-Dependent - therapy</subject><subject>Receptors, Estrogen - analysis</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE9LxDAQxYMo67r6EYRc9FZI0qZtjsviP1jwoueSJlM30iTdJD3UT2_A4mUew_sxzHsXaEt52RZNVfFLtCWEtAWvGnaNbmL8ziunhG_QhtG24aLdon4_J29lAo3Ps3TJJJmMd9gP2Fg7O6-W5NUJrFFyHBc8-qzmJ-MQU_Bf4HAABVPyIWLj8Gm20uE-gIwJK-kUhFt0Ncgxwt2qO_T5_PRxeC2O7y9vh_2xmFhZp6IsiSCDZlS3OUJFuda0BMmEBK5F1Te0ploJpRgMsuZ6UExQULqmPRU9I-UOPf7dnYI_z_m9zpqoYBylAz_HrhFNwymrM3i_gnNvQXdTMFaGpVtLyf7D6suY0w4hxzDxH6OirEmb5y_An25C</recordid><startdate>19900615</startdate><enddate>19900615</enddate><creator>MCCLELLAND, R. A</creator><creator>FINLAY, P</creator><creator>WALKER, K. J</creator><creator>NICHOLSON, D</creator><creator>ROBERTSON, J. F. R</creator><creator>BLAMEY, R. W</creator><creator>NICHOLSON, R. I</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19900615</creationdate><title>Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer</title><author>MCCLELLAND, R. A ; FINLAY, P ; WALKER, K. J ; NICHOLSON, D ; ROBERTSON, J. F. R ; BLAMEY, R. W ; NICHOLSON, R. I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p236t-33090fd21d8153415dd13ea29ae5d94b7161dc9cc2efa65dfc291ecd61b19b203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Biological and medical sciences</topic><topic>Breast - analysis</topic><topic>Breast Neoplasms - analysis</topic><topic>Breast Neoplasms - therapy</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>Immunoenzyme Techniques - instrumentation</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Neoplasms, Hormone-Dependent - analysis</topic><topic>Neoplasms, Hormone-Dependent - therapy</topic><topic>Receptors, Estrogen - analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MCCLELLAND, R. A</creatorcontrib><creatorcontrib>FINLAY, P</creatorcontrib><creatorcontrib>WALKER, K. J</creatorcontrib><creatorcontrib>NICHOLSON, D</creatorcontrib><creatorcontrib>ROBERTSON, J. F. R</creatorcontrib><creatorcontrib>BLAMEY, R. W</creatorcontrib><creatorcontrib>NICHOLSON, R. I</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MCCLELLAND, R. A</au><au>FINLAY, P</au><au>WALKER, K. J</au><au>NICHOLSON, D</au><au>ROBERTSON, J. F. R</au><au>BLAMEY, R. W</au><au>NICHOLSON, R. I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1990-06-15</date><risdate>1990</risdate><volume>50</volume><issue>12</issue><spage>3545</spage><epage>3550</epage><pages>3545-3550</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Frozen sections of breast tumor tissue have been stained using an immunoperoxidase [estrogen receptor (ER)-immunocytochemistry] kit incorporating a monoclonal antiserum [H222] to visualize nuclear human ERs. Quantitation of specific staining has been performed by manual procedures using optical microscopy and by a computer-assisted image analysis system (CAS 100). Initial investigations with a test panel of ER-immunocytochemistry-positive tumors revealed a good qualitative agreement between CAS and manual assessments. Reduced variance was, however, observed between quantified ER-immunocytochemistry results from four experienced investigators using the CAS analysis. An extended study confirmed the relationships between CAS and manual methods of assessment. These findings were evident when studies were scored either by assessment of the percentage of positively stained cells (n = 92; r = 0.919; P less than 0.01) or by H-score calculations (n = 92; r = 0.913; P less than 0.01). A good correlation was also found between CAS quantification and the results of an ER enzyme immunoassay of 48 primary breast cancer specimens (r = 0.715; P less than 0.05). In 49 cases it was possible to relate CAS-defined ER status and levels to the subsequent response of patients to endocrine therapy. ER was assessed on specimens obtained prior to commencement of treatments for recurrent breast cancer. Presuming the presence of ER to be a prerequisite for successful therapy, very good correlations between response and both status and levels of positivity were recorded. None of 16 patients with CAS-ER-negative tumors responded to treatment, while 16 of 33 (48.4%) CAS-ER-positive patients achieved an objective response according to International Union Against Cancer criteria. A relationship between response and the degree of CAS-ER positivity was obtained when the CAS score divisions of 0, 1-100, and greater than 100 (response rates, 0, 41, and 64%, respectively) were used. These data demonstrate that automated image analysis offers a reliable, reproducible procedure for quantifying ER in immunocytochemically stained sections. It has potential advantages over manual procedures, providing less opportunity for subjective influences in scoring sections. Future advances in software design should further reduce elements of subjectivity and increase both the speed and reliability of results. We anticipate image analysis becoming a valuable tool in investigations concerning, for example, the influence of heterogeneity of steroid receptor distribution on the rate of recurrence of breast cancer after mastectomy and in the clinical course of the disease.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>2187598</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1990-06, Vol.50 (12), p.3545-3550
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_79775126
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Biological and medical sciences
Breast - analysis
Breast Neoplasms - analysis
Breast Neoplasms - therapy
Female
Gynecology. Andrology. Obstetrics
Humans
Image Processing, Computer-Assisted
Immunoenzyme Techniques - instrumentation
Mammary gland diseases
Medical sciences
Neoplasms, Hormone-Dependent - analysis
Neoplasms, Hormone-Dependent - therapy
Receptors, Estrogen - analysis
Tumors
title Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A06%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Automated%20quantitation%20of%20immunocytochemically%20localized%20estrogen%20receptors%20in%20human%20breast%20cancer&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=MCCLELLAND,%20R.%20A&rft.date=1990-06-15&rft.volume=50&rft.issue=12&rft.spage=3545&rft.epage=3550&rft.pages=3545-3550&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E79775126%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79775126&rft_id=info:pmid/2187598&rfr_iscdi=true